Komori
Sekichu (9976) · RiskRestated

Occurrence and Spread of Serious Infectious Diseases Such as COVID-19

First written in FY2020. 8 of 17 entries say "Restated". Latest entry: FY2025.

17entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseSoftenedFY20242020: 420202021: 420212022: 420222023: 320232024: 120242025: 12025
Same theme, other companies
Risk of COVID-19 impacts on business activities, supply chains, demand and financial performanceA theme 1257 companies write about · 1269 as a headwind · 6 as a tailwind

The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 1283 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2025RestatedAnnual report

    「Although COVID-19 was reclassified as a Category 5 disease, the outbreak and spread of serious infectious diseases in the future could affect the Company's operating results and financial condition through a significant decline in customers and disruption to operations caused by employees contracting the diseases.」

    Even after COVID-19 was reclassified as a Category 5 disease, the company continues to identify the risk of customer declines and operational disruption resulting from future outbreaks and spread of serious infectious diseases.
  2. FY2024SoftenedAnnual report

    「Although COVID-19 was reclassified as a Category 5 disease, the outbreak and spread of serious infectious diseases in the future could affect the Company's operating results and financial condition through a significant decline in customers and disruption to operations caused by employees contracting the diseases.」

    The company explicitly notes the reclassification of COVID-19 as a Category 5 disease, changing from descriptions of the actual economic restrictions caused by the spread of infection to a focus on the possibility of future outbreaks and spread of serious infectious diseases.
  3. FY2024-Q3RestatedAnnual report

    「During the cumulative third quarter of the fiscal year, restrictions related to COVID-19 were eased and movement toward normalisation of social and economic activity was observed.」

    The company continues to explain that restrictions related to infectious diseases were eased and that movement toward normalisation of social and economic activity was observed.
  4. FY2024-Q2RestatedAnnual report

    「During the cumulative second quarter of the fiscal year, restrictions related to COVID-19 were eased and social and economic activity moved toward normalisation.」

    The company continues to explain that restrictions to address infectious diseases were eased and social and economic activity moved toward normalisation.
  5. FY2024-Q1SoftenedAnnual report

    「During the cumulative first quarter of the fiscal year, restrictions to address COVID-19 were eased and social and economic activity moved toward normalisation.」

    The description of COVID-19 has changed from the previous focus on concerns over a renewed spread of infection to a statement that restrictions to address the disease have been eased and social and economic activity has moved toward normalisation.
  6. FY2023-Q3RestatedAnnual report

    「During the cumulative third quarter of the fiscal year, restrictions related to COVID-19 were eased and movement toward normalisation of social and economic activity was observed. However, there was still no sign that the spread of infectious diseases was abating,」

    While restrictions related to infectious diseases were eased and social and economic activity was moving toward normalisation, the company states that there was still no sign that the spread of infectious diseases was abating, indicating that infectious disease risk continued.
  7. FY2023-Q2WorsenedAnnual report

    「During the cumulative second quarter of the fiscal year, restrictions related to COVID-19 were eased and movement toward normalisation of social and economic activity was observed. However, the seventh wave of infections was widespread in the immediate period,」

    The company states that restrictions related to infectious diseases were eased and economic activity was moving toward normalisation, while the seventh wave of infections was widespread, indicating that infectious disease risk had again become more serious.
  8. FY2023-Q1SoftenedAnnual report

    「During the cumulative first quarter of the fiscal year, although the risk of a renewed spread of COVID-19 remained, signs of a move toward recovery in social and economic activity emerged, including the lifting of priority preventive measures in all regions in March.」

    While stating that the risk of a renewed spread of infection remains, the company describes the lifting of priority preventive measures and movement toward recovery in social and economic activity, indicating a partial easing from the severe restrictions described through the previous year.
  9. FY2022RestatedAnnual report

    「During the fiscal year, the Japanese economy was subject to significant restrictions on economic activity due to the spread of COVID-19 and remained in an extremely difficult situation. While vaccinations progressed, the spread of new variant viruses continued, and states of emergency and priority preventive measures were repeatedly declared and lifted.」

    The company states that the impact of restrictions on economic activity caused by infectious diseases, variant viruses and states of emergency continued throughout the fiscal year.
  10. FY2022-Q3RestatedAnnual report

    「During the cumulative third quarter of the fiscal year, the Japanese economy was subject to significant restrictions on economic activity due to the spread of COVID-19 and remained in an extremely difficult situation. Although progress in vaccinations and the lifting of the state of emergency in all prefectures on 30 September indicated movement toward normalisation of economic activity, the outlook remained uncertain, with concerns over the spread of a new variant virus.」

    While significant restrictions on economic activity and difficult conditions caused by infectious diseases continued, the company also notes movement toward normalisation following the lifting of the state of emergency and concerns over a new variant virus.
  11. FY2022-Q2WorsenedAnnual report

    「During the first 2 quarters of the fiscal year, Japan's economy remained in an extremely challenging state due to the impact of the spread of COVID-19. Although a recovery is expected as vaccinations progress, the outlook remains uncertain as the original strain is being replaced by variants and states of emergency and priority preventive measures are being implemented in various regions.」

    While the impact of infectious diseases continues, the company notes the replacement of existing strains by variants and the implementation of states of emergency and priority preventive measures, indicating that difficult conditions continue before the situation is brought under control.
  12. FY2022-Q1WorsenedAnnual report

    「During the cumulative first quarter of the fiscal year, the Japanese economy remained in a difficult situation, with no prospect of the situation coming under control, as a state of emergency was reimposed in some regions due to the spread of COVID-19.」

    Regarding infectious disease risk, the company describes the continued impact from the previous fiscal year, the reimposition of a state of emergency in some regions and the absence of any prospect of the situation coming under control.
  13. FY2021RestatedAnnual report

    「During the fiscal year, the Japanese economy was subject to significant restrictions on economic activity due to the spread of COVID-19 and remained in an extremely difficult situation.」

    The company states that the significant restrictions on economic activity and difficult conditions caused by infectious diseases continued throughout the fiscal year, while also expressing expectations that vaccinations would bring the situation under control.
  14. FY2021-Q3RestatedAnnual report

    「During the first 3 quarters of the fiscal year, Japan's economy remained in an extremely challenging state, as the spread of COVID-19 placed significant constraints on economic activity. Although there have been signs of a resumption of economic activity, further spread of the infection is a concern at present, and the outlook remains uncertain.」

    Regarding infectious disease risk, the company states that significant restrictions on economic activity continue and that concerns remain over further spread of infection.
  15. FY2021-Q2WorsenedAnnual report

    「Economic activity deteriorated rapidly and remained in an extremely challenging state due to requests from the national and local governments to refrain from going out in response to the spread of COVID-19, as well as requests for companies to reduce operating hours or suspend operations.」

    The company continues to state that the impact of infectious diseases has actually occurred and specifies that economic activity deteriorated rapidly through requests to refrain from going out, shortened business hours and requests to suspend operations.
  16. FY2021-Q1MaterialisedAnnual report

    「During the cumulative first quarter of the fiscal year, the Japanese economy was significantly affected by the declaration of a state of emergency due to the spread of COVID-19. Although the state of emergency has since been lifted, concerns remain over a second and third wave of infections, and the outlook remains uncertain.」

    Regarding the infectious disease risk described as a possibility in the previous fiscal year, the company explains that the declaration of a state of emergency and a significant impact on economic activity actually occurred. It also notes concerns over a second and third wave in the future.
  17. FY2020First statedAnnual report

    「The recent outbreak and spread of COVID-19 and other serious infectious diseases could affect the Company's operating results and financial condition through a significant decline in customers and disruption to operations caused by employees contracting the diseases.」

    The company describes infectious diseases, including COVID-19, for the first time as an independent risk factor, citing the possibility of an impact on operating results and financial condition through customer declines and operational disruption caused by employees contracting the diseases.
Moved together

"Uncertainty in Overseas Economies, Foreign Exchange and Stock Markets" moved the same way as this thread, in the same document, in 5 of its 17 moves.

533222★123456
  1. ★This thread
  2. 1Uncertainty in Overseas Economies, Foreign Exchange and Stock Markets5×
  3. 2Building proposal-driven stores that make customers’ lives more comfortable3×
  4. 3Performance Trend of Declining Revenue and Rising Earnings3×
  5. 4Expanding real estate rental income through newly attracted tenants2×
  6. 5Impact of Adverse Weather Conditions, Including Rain and Typhoons2×
  7. 6Strong performance in the consumer electronics segment and weak performance in the household goods segment2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Sekichu yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Occurrence and Spread of Serious Infectious Diseases Such as COVID-19 | SEKICHU CO.,LTD. (9976) | Komori